Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1820 participants.
Also called NCT04893291
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,820 participants
- Registry
-
NCT04893291
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Bangladesh, Brazil, Brunei, France, Italy, Malaysia, Netherlands, Poland, Spain, Thailand, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04893291. Randomized; no masking; primary purpose treatment. Start 2021-11-16 (actual); primary completion 2026-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
- Acronym
- TRANSFORM II
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Stenosis
- Intervention (Device)
- Everolimus Eluting Stent
- Intervention (Device)
- Sirolimus Coated Balloon
- Lead sponsor
- Fondazione Ricerca e Innovazione Cardiovascolare ETS
Record details
- Record id
cardio:ct-nct04893291- Content hash
ca0fc2fb96f782418656152f2cedf2e198e0a8088a1f9828b4db010471021c56